Cancer Institute A national cancer institute
designated cancer center

Branimir I. Sikic, M. D.

Publication Details

  • Alteration of etoposide pharmacokinetics and pharmacodynamics by cyclosporine in a phase I trial to modulate multidrug resistance.

    Lum BL, Kaubisch S, Yahanda AM, Adler KM, Jew L, Ehsan MN, Brophy NA, Halsey J, Gosland MP, Sikic BI. J Clin Oncol. 1992; 10 (10): 1635-42

    To determine the effects of high-dose cyclosporine (CsA) infusion on the pharmacokinetics of etoposide in patients with cancer.

    PubMedID: 1403041

Stanford Medicine Resources:

Footer Links: